Work

Immunological targeting of CD133 in recurrent glioblastoma: A multi-center phase I translational and clinical study of autologous CD133 dendritic cell immunotherapy.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.2059

Authors: Jeremy David Rudnick, Karen L. Fink, Joseph C. Landolfi, James Markert, David Eric Piccioni, Michael J. Glantz, Steven J. Swanson, Anthony Gringeri, John Yu

Institutions: Cedars-Sinai Medical Center, John F. Kennedy Medical Center, University of Alabama at Birmingham, University of California San Diego, Moores Cancer Center, Penn State Milton S. Hershey Medical Center, ImmunoCellular Therapeutics (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2673666934

Cites:

Cited by: 21

Related to: 10